Larimar Therapeutics Inc (LRMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -165,673 | -80,604 | -36,949 | -35,355 | -50,636 |
| Depreciation Amortization | -1,348 | -4,938 | -1,532 | -456 | 312 |
| Accounts payable and accrued liabilities | 2,792 | 1,141 | -403 | 26 | -974 |
| Other Working Capital | 47,097 | 6,175 | -2,511 | 1,669 | 2,732 |
| Other Operating Activity | 3,931 | 7,466 | 7,936 | 6,547 | 6,461 |
| Operating Cash Flow | $-113,201 | $-70,760 | $-33,459 | $-27,569 | $-42,105 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 100,400 | -84,872 | 33,517 | -90,860 | 24,502 |
| PPE Investments | -91 | -515 | -164 | -100 | -333 |
| Investing Cash Flow | $100,309 | $-85,387 | $33,353 | $-90,960 | $24,169 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 65,086 | 161,883 | 30 | 75,257 | 19,885 |
| Financing Cash Flow | $65,086 | $161,883 | $30 | $75,257 | $19,885 |
| Beginning Cash Position | 33,824 | 28,088 | 28,164 | 71,436 | 69,487 |
| End Cash Position | 86,018 | 33,824 | 28,088 | 28,164 | 71,436 |
| Net Cash Flow | $52,194 | $5,736 | $-76 | $-43,272 | $1,949 |
| Free Cash Flow | |||||
| Operating Cash Flow | -113,201 | -70,760 | -33,459 | -27,569 | -42,105 |
| Capital Expenditure | -91 | -515 | -164 | -100 | -333 |
| Free Cash Flow | -113,292 | -71,275 | -33,623 | -27,669 | -42,438 |